Gemina Laboratories Ltd. (CSE:GLAB)
Canada · Delayed Price · Currency is CAD 0.0600
0.00 (0.00%)
Jan 9, 2026, 9:05 AM EST
Gemina Laboratories Market Cap
Gemina Laboratories has a market cap or net worth of CAD 4.59 million as of January 20, 2026. Its market cap has decreased by -87.21% in one year.
Market Cap
4.59M
Enterprise Value
4.83M
Revenue
10.88K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.06
Market Cap Chart
Since August 11, 2021, Gemina Laboratories's market cap has decreased from 21.35M to 4.59M, a decrease of -78.48%. That is a compound annual growth rate of -29.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 7, 2026 | 4.59M | - |
| Dec 31, 2025 | 4.59M | -92.23% |
| Dec 27, 2024 | 59.14M | 49.36% |
| Dec 29, 2023 | 39.60M | 23.55% |
| Dec 30, 2022 | 32.05M | 49.59% |
| Dec 29, 2021 | 21.43M | 0.35% |
| Aug 11, 2021 | 21.35M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |